NCT00024570 - Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2000

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

Malignant GliomaGlioblastoma MultiformeAnaplastic AstrocytomaMixed Oligoastrocytoma

Interventions

DRUG

IL13-PE38QQR

PROCEDURE

targeted fusion protein therapy

PROCEDURE

surgery

Trial Locations (8)

The Johns Hopkins University, Baltimore

Wake Forest University, Winston-Salem

Emory University, Atlanta

H. Lee Moffitt Cancer Center, Tampa

Cleveland Clinic, Cleveland

Henry Ford Health Systems, Detroit

University of Alabama at Birmingham, Birmingham

University of Pennsylvania, Philadelphia